Abstract
Over the past decade, oxidative stress has been established as the earliest cytological feature of Alzheimer disease and an attractive therapeutic target. The major challenges now are establishing the source of the reactive oxygen and what oxidative stress tells us about the etiology of Alzheimer disease. These are complex issues since a variety of enzymatic and nonenzymatic processes are involved in reactive oxygen formation and damage to macromolecules. In this review, we consider disease mechanisms that show the greatest promise for future research.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Corral-Debrinski M,Horton T,Lou MT,Shoffner JM,McKee AC,Beal MF,Graham BH,Wallace DC (1994) Marked changes in mitochondrial DNA deletion levels in Alzheimer brains.Genomics 23:471–476
Cuajungco MP,Goldstein LE,Nunomura A,Smith MA,Lim JT,Atwood CS,Huang X,Farrag YW,Perry G,Bush AI (2000) Evidence that the B-amyloid plaques of Alzheimer’s disease represent the redox-silencing and entombment of AB by zinc.J BioI Chern 275:19439–19442
Hattori N,Kitagawa K,Higashida T,Yagyu K,Shimohama S,Wataya T,Perry G,Smith MA,Inagaki C (1998) Cl--ATPase and Na+/K+-ATPase activities in Alzheimer’s disease brains.Neurosci Lett 254:141–144
Hirai K,Aliev G,Nunomura A,Fujioka H,Russell RL,Atwood CS,Johnson AB,Kress Y,Vinters HV,Tabaton M,Shimohama S,Cash AD,Siedlak SL,Harris PLR,Jones PK,Petersen RB,Perry G,Smith MA (2001) Mitochondrial abnormalities in Alzheimer’s disease.J Neurosci 21:3017–3023
Nunomura A,Perry G,Pappolla MA,Wade R,Hirai K,Chiba S,Smith MA (1999) RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer’s disease.J Neurosci 19:1959–1964
Nunomura A, Perry G, Pappolla MA, Friedland RP, Hirai K, Chiba S, Smith MA(2000) Neuronal oxidative stress precedes amyloid-B deposition in Down syndrome. J Neuropathol Exp Neurol 59: 1011–1017
Nunomura A,Perry G,Aliev G,Hirai K,Takeda A,Balraj EK,Jones PK,Ghanbari H,Wataya T,Shimohama S,Chiba S,Atwood CS,Petersen RB,Smith MA (2001) Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 60:759–767
Pappolla MA,Omar RA,Chyan Y-J,Ghiso J,Hsiao K,Bozner P,Perry G,Smith MA,Cruz-Sanchez F (2001) Induction of NADPH cytochrome P450 reductase by the Alzheimer B-protein. Amyloid as a “foreign body”. J Neurochem 78:121–128
Perez M,Cuadros R,Smith MA,Perry G,Avila J (2000) Phosphorylated, but not native, tau protein assembles following reaction with the lipid peroxidation product, 4hydroxy-2-nonenal.FEBS LeU 486:270--274
Perry G,Nunomura A,Raina AK,Smith MA (2000) Amyloid-B junkies.Lancet 355:757
Perry G, Zhu X, Smith MA (2001) Do neurons have a choice in death? Am J Pathol158: 1–274 G. Perry et al.
Praprotnik D, Smith MA, Richey PL, Vinters HV, Perry G (1996a) Plasma membrane fragility in dystrophic neurites in senile plaques of Alzheimer’s disease: an index of oxidative stress. Acta Neuropathol 91: 1–5
Praprotnik D, Smith MA, Richey PL, Vinters HV, Perry G (1996b) Filament heterogeneity within the dystrophic neurites of senile plaques suggests blockage of fast axonal transport in Alzheimer’s disease. Acta Neuropathol 91: 226–235
Sayre LM, Zelasko DA, Harris PLR, Perry G, Salomon RG, Smith MA (1997) 4Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer’s disease. J Neurochem 68: 2092–2097
Shimohama S, Tanino H, Kawakami N, Okamura N, Kodama H, Yamaguchi T, Hayakawa T, Nunomura A, Chiba S, Perry G, Smith MA, Fujimoto S (2000) Activation of NADPH oxidase in Alzheimer’s disease brains. Biochem Biophys Res Cornmun 273: 5–9
Small GW, Komo S, La Rue A, Saxena S, Phelps ME, Mazziotta JC, Saunders AM, Haines JL, Pericak-Vance MA, Roses AD (1996) Early detection of Alzheimer’s disease by combining apolipoprotein E and neuroimaging. AnnNY Acad Sci 802: 7078
Smith CD, Carney JM, Starke-Reed PE, Oliver CN, Stadtman ER, Floyd RA, Markesbery WR (1991) Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc Natl Acad Sci USA 88: 10540-10543
Smith MA, Taneda S, Richey PL, Miyata S, Yan S-D, Stern D, Sayre LM, Monnier VM, Perry G (1994) Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci USA 91: 5710–5714
Smith MA, Perry G, Richey PL, Sayre LM, Anderson VE, Beal MF, Kowall N (1996) Oxidative damage in Alzheimer’s. Nature 382: 120–121 Smith MA, Harris PLR, Sayre LM, Beckman JS, Perry G (1997a) Widespread peroxynitrite-mediated damage in Alzheimer’s disease. J Neurosci 17: 2653–2657
Smith MA, Harris PLR, Sayre LM, Perry G (1997b) Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci USA 94: 9866–9868
Smith MA, Sayre LM, Anderson VE, Harris PLR, Beal MF, Kowall N, Perry G (1998) Cytochemical demonstration of oxidative damage in Alzheimer disease by immunochemical enhancement of the carbonyl reaction with 2,4-dinitrophenylhydrazine. J Histochem Cytochem 46: 731–735
Smith MA, Joseph JA, Perry G (2000) Arson: tracking the culprit in Alzheimer’s disease. Ann NY Acad Sci 924: 35–38
Takeda A, Perry G, Abraham NG, Dwyer BE, Kutty RK, Laitinen IT, Petersen RB, Smith MA (2000a) Overexpression of heme oxygenase in neuronal cells, the possible interaction with tau. J Bioi Chern 275: 5395–5399
Takeda A, Smith MA, Avila J, Nunomura A, Siedlak SL, Zhu X, Perry G, Sayre LM (2000b) In Alzheimer’s disease, heme oxygenase is coincident with Alz50, an epitope of’t induced by 4-hydroxy-2-nonenal modification. J Neurochem 75: 1234-1241
Terry RD (1996) The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis. J Neuropathol Exp Neurol 55: 1023–1025
Terry RD (2000) Cell death or synaptic loss in Alzheimer disease. J Neuropathol Exp Neurol 59: 1118–1119
Wallace DC, Stugard C, Murdock D, Schurr T, Brown MD (1997) Ancient mtDNA sequences in the human nuclear genome: a potential source of errors in identifying pathogenic mutations. Proc Natl Acad Sci USA 94: 14900–14905
Wataya T, Nunomura A, Smith MA, Siedlak SL, Harris PLR, Shimoharna S, Szweda LI, Kaminski MA, Avila J, Price DL, Cleveland DW, Sayre LM, Perry G (2002) High molecular weight neurofilament proteins are physiological substrates of adduction by the lipid peroxidation product hydroxynonenal. J Bioi Chern 277: 4644–4648
Yan SD, Yan SF, Chen X, Fu J, Chen M, Kuppusamy P, Smith MA, Perry G, Godman GC, Nawroth P, Zweier JL, Stern D (1995) Non-enzymatically glycated tau in Alzheimer’s disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid B-peptide. Nat Med 1: 693–699
Zhou F, Zhu X, Castellani RJ, Stimmelymayr R, Perry G, Smith MA, Drew KL (2001) Hibernation, a model of neuroprotection. Am J Pathol 158: 2145–2151
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Wien
About this paper
Cite this paper
Perry, G. et al. (2002). Reactive oxygen: its sources and significance in Alzheimer disease. In: Jellinger, K.A., Schmidt, R., Windisch, M. (eds) Ageing and Dementia Current and Future Concepts. Journal of Neural Transmission. Supplementa, vol 62. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6139-5_7
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6139-5_7
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-83796-2
Online ISBN: 978-3-7091-6139-5
eBook Packages: Springer Book Archive